# SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®

Study · id `cardio:ct-nct01956448` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01956448](<https://clinicaltrials.gov/study/NCT01956448>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01956448

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2800 participants.

## Technical summary

Registry record NCT01956448. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2800 participants (enrolled count; ClinicalTrials.gov record NCT01956448, source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01956448, source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)
- Primary completion: 2012-07 (actual) (ClinicalTrials.gov record NCT01956448, source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)
- Completion: 2012-07 (actual) (ClinicalTrials.gov record NCT01956448, source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT01956448, source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01956448-2013-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®
- Acronym: SO VI
- Condition: Coronary Artery Disease
- Condition: Angina Pectoris
- Intervention (Device): Drug eluting stent
- Lead sponsor: Aarhus University Hospital Skejby
- Lead sponsor class: OTHER
- Collaborator: Biosensors International
- Collaborator class: OTHER
- Collaborator: Medtronic Cardiovascular
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Drug-eluting stent (`cardio:drug-eluting-stent`)
- Registry lists this organization as the lead sponsor: Aarhus University Hospital Skejby (`cardio:org-aarhus-university-hospital-skejby`)
- Registry lists this organization as a collaborator: Biosensors International (`cardio:org-biosensors-international`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial (`cardio:pubmed-25601789`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial (`cardio:pubmed-28109874`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 226ae26e2e92aae097c7a3389667aae06a67b47500366cb4330c654d60f9ddcb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
